An early-stage non-US. technology company developed a digital audible biomarker monitor urinary health conditions and wanted to take their product to market.
Identified a high-value clinical need: We evaluated current clinical uses of uroflowmeters, conducted expert and key user interviews to arrive at a clinical condition to focus on for the beachhead use case
Analyzed for a white-space in the market: We analyzed the direct and indirect competitors to define a differentiated value proposition using the unique features offered in our client’s product.
Developed a launch strategy: Using our proprietary framework for prioritization, we analyzed potential channels and associated value propositions. We also developed a reimbursement strategy making the product a revenue-generator for providers and our client. With a multi-step go-to-market (GTM) strategy crafted, we created a plan to begin strategic networking, increase visibility and credibility, and obtain clinical validation.